132 related articles for article (PubMed ID: 37246339)
1. Experience with the US health care system for Black and White patients with advanced prostate cancer.
Rencsok EM; Stopsack KH; Slopen N; Odedina FT; Ragin C; Nowak J; McSwain L; Manarite J; Heath E; George DJ; Kantoff PW; Vinson J; Villanti P; Haneuse S; Mucci LA;
Cancer; 2023 Aug; 129(16):2532-2541. PubMed ID: 37246339
[TBL] [Abstract][Full Text] [Related]
2. Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United States.
Rencsok EM; Slopen N; McManus HD; Autio KA; Morgans AK; McSwain L; Barata P; Cheng HH; Dreicer R; Gerke T; Green R; Heath EI; Howard LE; McKay RR; Nowak J; Pileggi S; Pomerantz MM; Rathkopf DE; Tagawa ST; Whang YE; Ragin C; Odedina FT; Kantoff PW; Vinson J; Villanti P; Haneuse S; Mucci LA; George DJ;
Cancer Res Commun; 2024 Jan; 4(1):55-64. PubMed ID: 38108490
[TBL] [Abstract][Full Text] [Related]
3. Quality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US.
Rencsok EM; Slopen N; Autio K; Morgans A; McSwain L; Barata P; Cheng HH; Dreicer R; Heath E; McKay RR; Pomerantz M; Rathkopf D; Tagawa S; Whang YE; Ragin C; Odedina FT; George DJ; Kantoff PW; Vinson J; Villanti P; Haneuse S; Mucci LA;
Qual Life Res; 2023 Nov; 32(11):3209-3221. PubMed ID: 37410340
[TBL] [Abstract][Full Text] [Related]
4. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
5. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
[TBL] [Abstract][Full Text] [Related]
6. Racial differences in the treatment and outcomes for prostate cancer in Massachusetts.
Cole AP; Herzog P; Iyer HS; Marchese M; Mahal BA; Lipsitz SR; Nyambose J; Gershman ST; Kennedy M; Merriam G; Rebbeck TR; Trinh QD
Cancer; 2021 Aug; 127(15):2714-2723. PubMed ID: 33999405
[TBL] [Abstract][Full Text] [Related]
7. An editorial on a comparison of care quality metrics between Black and White men with advanced prostate cancer in the IRONMAN registry.
Murphy AB
Cancer; 2023 Aug; 129(16):2453-2455. PubMed ID: 37246344
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer risk factors in black and white men in the NIH-AARP Diet and Health Study.
Layne TM; Graubard BI; Ma X; Mayne ST; Albanes D
Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):91-100. PubMed ID: 30108373
[TBL] [Abstract][Full Text] [Related]
9. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysis.
Vince RA; Jiang R; Bank M; Quarles J; Patel M; Sun Y; Hartman H; Zaorsky NG; Jia A; Shoag J; Dess RT; Mahal BA; Stensland K; Eyrich NW; Seymore M; Takele R; Morgan TM; Schipper M; Spratt DE
JAMA Netw Open; 2023 Jan; 6(1):e2250416. PubMed ID: 36630135
[TBL] [Abstract][Full Text] [Related]
11. A multidimensional view of racial differences in access to prostate cancer care.
Pollack CE; Armstrong KA; Mitra N; Chen X; Ward KR; Radhakrishnan A; Wong MS; Bekelman JE; Branas CC; Rhodes KV; Grande DT
Cancer; 2017 Nov; 123(22):4449-4457. PubMed ID: 28727136
[TBL] [Abstract][Full Text] [Related]
12. Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study.
Tyson MD; Alvarez J; Koyama T; Hoffman KE; Resnick MJ; Wu XC; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Paddock LE; Stroup A; Chen VW; Penson DF; Barocas DA
Eur Urol; 2017 Aug; 72(2):307-314. PubMed ID: 27816300
[TBL] [Abstract][Full Text] [Related]
13. Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate Cancer.
Leapman MS; Dinan M; Pasha S; Long J; Washington SL; Ma X; Gross CP
JAMA Oncol; 2022 May; 8(5):687-696. PubMed ID: 35238879
[TBL] [Abstract][Full Text] [Related]
14. Willingness to Discuss Clinical Trials Among Black vs White Men With Prostate Cancer.
Senft N; Hamel LM; Manning MA; Kim S; Penner LA; Moore TF; Carducci MA; Heath EI; Lansey DG; Albrecht TL; Wojda M; Jordan A; Eggly S
JAMA Oncol; 2020 Nov; 6(11):1773-1777. PubMed ID: 32940630
[TBL] [Abstract][Full Text] [Related]
15. Cancer mortality in the United States by education level and race.
Albano JD; Ward E; Jemal A; Anderson R; Cokkinides VE; Murray T; Henley J; Liff J; Thun MJ
J Natl Cancer Inst; 2007 Sep; 99(18):1384-94. PubMed ID: 17848670
[TBL] [Abstract][Full Text] [Related]
16. Differences in the prevalence of modifiable risk and protective factors for prostate cancer by race and ethnicity in the National Health and Nutrition Examination Survey.
Defever K; Platz EA; Lopez DS; Mondul AM
Cancer Causes Control; 2020 Sep; 31(9):851-860. PubMed ID: 32666408
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. Income inequality and treatment of African American men with high-risk prostate cancer.
Ziehr DR; Mahal BA; Aizer AA; Hyatt AS; Beard CJ; D Amico AV; Choueiri TK; Elfiky A; Lathan CS; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
Urol Oncol; 2015 Jan; 33(1):18.e7-18.e13. PubMed ID: 25306287
[TBL] [Abstract][Full Text] [Related]
19. Association of Race and Ethnicity and Medicare Program Type With Ambulatory Care Access and Quality Measures.
Johnston KJ; Hammond G; Meyers DJ; Joynt Maddox KE
JAMA; 2021 Aug; 326(7):628-636. PubMed ID: 34402828
[TBL] [Abstract][Full Text] [Related]
20. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity.
Powell IJ; Bock CH; Ruterbusch JJ; Sakr W
J Urol; 2010 May; 183(5):1792-6. PubMed ID: 20299055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
